인쇄하기
취소
|
It was known that multinational pharmaceutical companies are reviewing a plan to increase distribution cost by pressure of the pharmaceutical distribution industry.
So far, multinational pharmaceutical companies raised complaints of distribution companies as providing distribution cost that is not even close to the break-even point. Although their break-even point is late 8%, multinational pha...